{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:39:34Z","timestamp":1792669174445,"version":"4.5.0"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OVV-152411"],"award-info":[{"award-number":["OVV-152411"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00361","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T02:18:17Z","timestamp":1583806697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["Advances in Developing CAR T-Cell Therapy for HIV Cure"],"prefix":"10.3389","volume":"11","author":[{"given":"Jinxin","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1007\/s00018-019-03156-8","article-title":"Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs","volume":"76","author":"Sadowski","year":"2019","journal-title":"Cell Mol Life Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/v11030269","article-title":"Cat and mouse: HIV transcription in latency, immune evasion and cure\/remission strategies","volume":"11","author":"Delannoy","year":"2019","journal-title":"Viruses."},{"key":"B4","doi-asserted-by":"publisher","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1000533","DOI":"10.1371\/journal.pcbi.1000533","article-title":"Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy","volume":"5","author":"Rong","year":"2009","journal-title":"PLoS Comput Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-Redondo","year":"2016","journal-title":"Nature."},{"key":"B11","first-page":"75","article-title":"Morbidity in older HIV-infected patients: impact of long-term antiretroviral use","volume":"16","author":"Guaraldi","year":"2014","journal-title":"AIDS Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1093\/jac\/dkw218","article-title":"Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa","volume":"71","author":"Boender","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/cid\/ciu590","article-title":"Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis","volume":"59","author":"Liu","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature."},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41591-019-0549-5","article-title":"Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR","volume":"25","author":"Ghorashian","year":"2019","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1128\/JVI.00474-15","article-title":"Novel CD4-based bispecific chimeric antigen receptor designed for enhanced anti-HIV potency and absence of HIV entry receptor activity","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1006753","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"PLoS Pathog."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1182\/blood-2007-06-097907","article-title":"CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency","volume":"110","author":"Saleh","year":"2007","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1128\/JVI.74.17.7824-7833.2000","article-title":"Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1","volume":"74","author":"Pierson","year":"2000","journal-title":"J Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1073\/pnas.94.5.1925","article-title":"The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes","volume":"94","author":"Bleul","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"E4762","DOI":"10.1073\/pnas.1423228112","article-title":"Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor","volume":"112","author":"Gornalusse","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.immuni.2017.09.014","article-title":"Transcriptional reprogramming during effector-to-memory transition renders CD4(+) T Cells permissive for latent HIV-1 infection","volume":"47","author":"Shan","year":"2017","journal-title":"Immunity."},{"key":"B25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"Whitney","year":"2014","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1128\/JVI.78.3.1160-1168.2004","article-title":"T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis","volume":"78","author":"Brenchley","year":"2004","journal-title":"J Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1128\/JVI.00591-06","article-title":"Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells","volume":"80","author":"Bailey","year":"2006","journal-title":"J Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9625","DOI":"10.1128\/JVI.79.15.9625-9634.2005","article-title":"Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus","volume":"79","author":"Tobin","year":"2005","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/COH.0000000000000438","article-title":"HIV integration sites and implications for maintenance of the reservoir","volume":"13","author":"Symons","year":"2018","journal-title":"Curr Opin HIV AIDS."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E2575","DOI":"10.1073\/pnas.1720665115","article-title":"Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cell.2015.01.020","article-title":"HIV-1 integration landscape during latent and active infection","volume":"160","author":"Cohn","year":"2015","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"Simonetti","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4(+) T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1006230","DOI":"10.1371\/journal.ppat.1006230","article-title":"Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells","volume":"13","author":"Bui","year":"2017","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"E7908","DOI":"10.1073\/pnas.1617789113","article-title":"Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA","volume":"113","author":"Lorenzi","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice","volume":"10","author":"Dash","year":"2019","journal-title":"Nat Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.272.5263.809","article-title":"Likely HIV cofactor found","volume":"272","author":"Cohen","year":"1996","journal-title":"Science."},{"key":"B43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nm0397-252","article-title":"HIV-1 infection in an individual homozygous for the CCR5 deletion allele","volume":"3","author":"Biti","year":"1997","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nm1197-1259","article-title":"In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression","volume":"3","author":"Scarlatti","year":"1997","journal-title":"Nat Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood."},{"key":"B48","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-Edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N Engl J Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-019-0459-6","article-title":"CCR5-32 is deleterious in the homozygous state in humans","volume":"25","author":"Wei","year":"2019","journal-title":"Nat Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1371\/journal.pbio.0020234","article-title":"Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences","volume":"2","author":"Mitchell","year":"2004","journal-title":"PLoS Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ebiom.2016.04.039","article-title":"LEDGIN-mediated inhibition of integrase-LEDGF\/p75 interaction reduces reactivation of residual latent HIV","volume":"8","author":"Vranckx","year":"2016","journal-title":"EBioMedicine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2012.05.016","article-title":"An analog of the natural steroidal alkaloid cortistatin a potently suppresses tat-dependent HIV transcription","volume":"12","author":"Mousseau","year":"2012","journal-title":"Cell Host Microbe."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e00465","DOI":"10.1128\/mBio.00465-15","article-title":"The tat Inhibitor didehydro-cortistatin a prevents HIV-1 reactivation from latency","volume":"6","author":"Mousseau","year":"2015","journal-title":"MBio."},{"key":"B55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/9498","article-title":"Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy","volume":"5","author":"Chun","year":"1999","journal-title":"Nat Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/00002030-199912030-00012","article-title":"Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy","volume":"13","author":"Prins","year":"1999","journal-title":"AIDS."},{"key":"B57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"Shan","year":"2012","journal-title":"Immunity."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1003834","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"Spina","year":"2013","journal-title":"PLoS Pathog."},{"key":"B59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/aid.2008.0191","article-title":"Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid","volume":"25","author":"Archin","year":"2009","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/QAD.0b013e32835535f5","article-title":"Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients","volume":"26","author":"Bouchat","year":"2012","journal-title":"AIDS."},{"key":"B61","doi-asserted-by":"publisher","first-page":"16538","DOI":"10.1074\/jbc.M110.103531","article-title":"Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294","volume":"285","author":"Imai","year":"2010","journal-title":"J Biol Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1128\/AAC.02625-15","article-title":"Elevated plasma viral loads in romidepsin-treated simian immunodeficiency virus-infected rhesus macaques on suppressive combination antiretroviral therapy","volume":"60","author":"Del Prete","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"10803","DOI":"10.1128\/JVI.00320-14","article-title":"The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events","volume":"88","author":"Lucera","year":"2014","journal-title":"J Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tim.2013.02.005","article-title":"Reactivation of latent HIV by histone deacetylase inhibitors","volume":"21","author":"Shirakawa","year":"2013","journal-title":"Trends Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1004071","DOI":"10.1371\/journal.ppat.1004071","article-title":"Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing","volume":"10","author":"Wei","year":"2014","journal-title":"PLoS Pathog."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00002030-200209060-00006","article-title":"In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific","volume":"16","author":"Demoustier","year":"2002","journal-title":"AIDS."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.168.6.3099","article-title":"A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape","volume":"168","author":"Douek","year":"2002","journal-title":"J Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12981-017-0177-4","article-title":"Eradication of HIV-1 latent reservoirs through therapeutic vaccination","volume":"14","author":"Pankrac","year":"2017","journal-title":"AIDS Res Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e02166","DOI":"10.1128\/JVI.02166-16","article-title":"Toll-like receptor 7 agonist GS-9620 induces HIV expression and HIV-specific immunity in cells from HIV-infected individuals on suppressive antiretroviral therapy","volume":"91","author":"Tsai","year":"2017","journal-title":"J Virol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"Sogaard","year":"2015","journal-title":"PLoS Pathog."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1004278","DOI":"10.1371\/journal.ppat.1004278","article-title":"A tick gut protein with fibronectin III domains aids Borrelia burgdorferi congregation to the gut during transmission","volume":"10","author":"Narasimhan","year":"2014","journal-title":"PLoS Pathog."},{"key":"B73","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1038\/ncomms7838","article-title":"Manipulation of B-cell responses with histone deacetylase inhibitors","volume":"6","author":"Waibel","year":"2015","journal-title":"Nat Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.1255512","article-title":"Immunologic strategies for HIV-1 remission and eradication","volume":"345","author":"Barouch","year":"2014","journal-title":"Science."},{"key":"B75","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1517\/14712598.2011.573476","article-title":"Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy","volume":"11","author":"Ramos","year":"2011","journal-title":"Expert Opin Biol Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov."},{"key":"B78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40364-017-0102-y","article-title":"Engineering CAR-T cells","volume":"5","author":"Zhang","year":"2017","journal-title":"Biomark Res."},{"key":"B79","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.161.6.2791","article-title":"Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product","volume":"161","author":"Finney","year":"1998","journal-title":"J Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.188.4.619","article-title":"Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes","volume":"188","author":"Krause","year":"1998","journal-title":"J Exp Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo","volume":"17","author":"Milone","year":"2009","journal-title":"Mol Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/hum.2009.122","article-title":"4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies","volume":"21","author":"Tammana","year":"2010","journal-title":"Hum Gene Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","article-title":"TRUCKs: the fourth generation of CARs","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expert Opin Biol Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-Cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu Rev Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci Transl Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science."},{"key":"B90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/COH.0b013e328344f35e","article-title":"Epidemiology and clinical characteristics of elite controllers","volume":"6","author":"Okulicz","year":"2011","journal-title":"Curr Opin HIV AIDS."},{"key":"B91","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.4049\/jimmunol.0900111","article-title":"Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity","volume":"182","author":"Loffredo","year":"2009","journal-title":"J Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype","volume":"104","author":"Saez-Cirion","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nm0297-205","article-title":"Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus","volume":"3","author":"Borrow","year":"1997","journal-title":"Nat Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature14053","article-title":"Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations","volume":"517","author":"Deng","year":"2015","journal-title":"Nature."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e29717","DOI":"10.1371\/journal.pone.0029717","article-title":"CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control","volume":"7","author":"Mothe","year":"2012","journal-title":"PLoS ONE."},{"key":"B97","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1006\/mthe.2002.0611","article-title":"A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy","volume":"5","author":"Deeks","year":"2002","journal-title":"Mol Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1128\/JVI.00805-16","article-title":"HIV-1-specific chimeric antigen receptors based on broadly neutralizing antibodies","volume":"90","author":"Ali","year":"2016","journal-title":"J Virol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ymthe.2016.12.023","article-title":"Engineering HIV-resistant, anti-HIV chimeric antigen receptor T cells","volume":"25","author":"Hale","year":"2017","journal-title":"Mol Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"11478","DOI":"10.1073\/pnas.94.21.11478","article-title":"Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells","volume":"94","author":"Yang","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B101","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning","volume":"13","author":"Kwong","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/34929","article-title":"HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes","volume":"391","author":"Collins","year":"1998","journal-title":"Nature."},{"key":"B103","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nm0396-338","article-title":"Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein","volume":"2","author":"Schwartz","year":"1996","journal-title":"Nat Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00262-012-1254-0","article-title":"Targeted immunotherapy of cancer with CAR T cells: achievements and challenges","volume":"61","author":"Lipowska-Bhalla","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"B105","doi-asserted-by":"publisher","first-page":"132ra53","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci Transl Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","article-title":"Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals","volume":"179","author":"Thompson","year":"2011","journal-title":"Am J Pathol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"eaav5685","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"Anthony-Gonda","year":"2019","journal-title":"Sci Transl Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1182\/blood.V96.3.785","article-title":"Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus-infected subjects","volume":"96","author":"Mitsuyasu","year":"2000","journal-title":"Blood."},{"key":"B110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/4716","article-title":"In vivo migration and function of transferred HIV-1-specific cytotoxic T cells","volume":"5","author":"Brodie","year":"1999","journal-title":"Nat Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nm0296-216","article-title":"T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients","volume":"2","author":"Riddell","year":"1996","journal-title":"Nat Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1182\/blood.V93.5.1506","article-title":"Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome","volume":"93","author":"Tan","year":"1999","journal-title":"Blood."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1182\/blood-2010-01-043737","article-title":"Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor","volume":"116","author":"Jena","year":"2010","journal-title":"Blood."},{"key":"B114","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.coi.2009.02.009","article-title":"The promise and potential pitfalls of chimeric antigen receptors","volume":"21","author":"Sadelain","year":"2009","journal-title":"Curr Opin Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1126\/science.aar3246","article-title":"Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes","volume":"359","author":"Sockolosky","year":"2018","journal-title":"Science."},{"key":"B116","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature."},{"key":"B117","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4177::AID-IMMU4177>3.0.CO;2-J","article-title":"Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120","volume":"28","author":"Bitton","year":"1998","journal-title":"Eur J Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J Exp Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbrc.2015.05.026","article-title":"Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4zeta CAR from HIV-1 infection and alleviates impairment of cell proliferation","volume":"463","author":"Kamata","year":"2015","journal-title":"Biochem Biophys Res Commun."},{"key":"B121","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcyt.2017.11.001","article-title":"Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity","volume":"20","author":"Ghanem","year":"2018","journal-title":"Cytotherapy."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/0092-8674(91)90327-U","article-title":"Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides","volume":"64","author":"Romeo","year":"1991","journal-title":"Cell."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4(+): CD8(+) composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J Clin Invest."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T Cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood-2016-07-730689","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"128","author":"Lee","year":"2016","journal-title":"Blood."},{"key":"B127","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e1006613","DOI":"10.1371\/journal.ppat.1006613","article-title":"Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor","volume":"13","author":"Leibman","year":"2017","journal-title":"Plos Pathog."},{"key":"B129","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2018.00492","article-title":"Simian immunodeficiency virus (SIV)-specific chimeric antigen receptor-T cell engineered to target B cell follicles and suppress SIV replication","volume":"9","author":"Haran","year":"2018","journal-title":"Front Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"aab4077","DOI":"10.1126\/science.aab4077","article-title":"Remote control of therapeutic T cells through a small molecule-gated chimeric receptor","volume":"350","author":"Wu","year":"2015","journal-title":"Science."},{"key":"B131","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1182\/blood-2012-01-405365","article-title":"A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR","volume":"119","author":"Torikai","year":"2012","journal-title":"Blood."},{"key":"B132","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.omtm.2016.12.008","article-title":"Homology-directed recombination for enhanced engineering of chimeric antigen receptor T cells","volume":"4","author":"Hale","year":"2017","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s13238-017-0415-5","article-title":"Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV","volume":"8","author":"Liu","year":"2017","journal-title":"Protein Cell."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mt.2015.102","article-title":"HIV-specific immunity derived from chimeric antigen receptor-engineered stem cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol Ther."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00361\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:23:47Z","timestamp":1695885827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00361\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":134,"alternative-id":["10.3389\/fimmu.2020.00361"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00361","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"article-number":"361"}}